ADMA Biologics Inc revenue growth has been varied year-over-year.

What is ADMA's revenue growth rate?

Historical revenue data is available for ADMA Biologics Inc to analyze growth trends.

How fast is ADMA earnings growing?

Earnings growth data is available for ADMA Biologics Inc analysis.

What is ADMA's profit margin?

Profit margin data is available for ADMA Biologics Inc.

ADMA Revenue & Earnings Growth Analysis 2026 - Is ADMA Biologics Inc Growing?

Growth Summary

ADMA Biologics Inc (ADMA) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.

Over the past 4 years, ADMA Biologics Inc has achieved a revenue compound annual growth rate (CAGR) of 78.3%.

Latest Revenue

$426.45M

Net Income

$197.67M

5-Year Revenue CAGR

78.3%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for ADMA Biologics Inc

The chart above illustrates ADMA Biologics Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of ADMA Biologics Inc's business.

Profit Margin Trends

How efficiently ADMA Biologics Inc converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue ADMA Biologics Inc retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$1.04

Current: $0.85

EPS Estimate 2027

$1.38

32.7% expected growth

Price Target

$25.67

Analyst consensus

What Analysts Are Saying

Wall Street analysts project ADMA Biologics Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.3333 based on 3 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, ADMA Biologics Inc (ADMA) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 78.3% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of ADMA Biologics Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.